ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Q2 revenue rose 40% to ₹576 Cr with 25% operating EBITDA margin and ₹90 Cr PAT. Arena acquisition flatters growth, and recent plant inspections remain unresolved.
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Ltd reported revenue from operations of ₹576.4 Cr (+39.9% YoY) and net profit of ₹90.4 Cr (+67.7% YoY) for Q2 FY27.
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Rubicon Research scheduled its Board for November 5, 2026, to consider unaudited financial results for the half year ended September 2026. Trading window closed since October 1.
Rubicon Research Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, pursuant to Regulation 31(1)(b) of the LODR Regulations.
Rubicon Research reported the conclusion of a US FDA inspection at its Satara facility. The audit yielded one procedural observation unrelated to data integrity.
Rubicon Research allotted 7,200 equity shares under its Employee Stock Option Scheme 2022. This issuance marginally increases the company's total paid-up share capital.
Employee Girish Subramaniam Iyer sold 6,796 shares in the open market across four transactions for a total consideration of ₹1.23 Crore.